Pfizer: agreement with Gilead for Covid-19 treatment
(CercleFinance.com) - Pfizer has announced an agreement with Gilead to manufacture Remdesivir for the treatment of Covid-19.
As part of this agreement, Pfizer will provide contract manufacturing services at Pfizer's McPherson and Kansas factories to manufacture and supply remdesivir for Gilead.
"Pfizer's agreement with Gilead is an excellent example of members of the innovation ecosystem working together to deliver medical solutions,” said Albert Bourla, Chairman and Chief Executive Officer.
"it is a privilege to offer our expertise and infrastructure to help fight this pandemic. In that spirit, we are pleased that Gilead is using our manufacturing capacity to help facilitate supply of this medicine to patients as quickly as possible".
Copyright (c) 2020 CercleFinance.com. All rights reserved.
As part of this agreement, Pfizer will provide contract manufacturing services at Pfizer's McPherson and Kansas factories to manufacture and supply remdesivir for Gilead.
"Pfizer's agreement with Gilead is an excellent example of members of the innovation ecosystem working together to deliver medical solutions,” said Albert Bourla, Chairman and Chief Executive Officer.
"it is a privilege to offer our expertise and infrastructure to help fight this pandemic. In that spirit, we are pleased that Gilead is using our manufacturing capacity to help facilitate supply of this medicine to patients as quickly as possible".
Copyright (c) 2020 CercleFinance.com. All rights reserved.